The U.S. Department of Health and Human Services through its Administration for Children and Families (ACF) announced this week that three U.S. Food and Drug Administration-approved Medications for Opioid Use Disorder (MOUD) have been added as prevention services eligible for funding under Title IV-E, which supports children and families involved with the child welfare system.
States and tribes can now receive a 50 percent federal match to provide buprenorphine, methadone, and naltrexone to parents when children are at imminent risk of entering foster care but can remain safely in the home or in a kinship placement by providing access to these treatments. Following President Trump’s new Executive Order, Addressing Addiction Through the Great American Recovery Initiative, this expansion gives states new resources to address the opioid crisis, stabilize families, and prevent entries into foster care.
Dear Colleague Letter on Keeping Families Together with Expanded Access to Medications for Opioid Use Disorder
SAMHSA, ACF, and the Centers for Medicare and Medicaid issued a Dear Colleague Letter encouraging states, tribes, territories, and local partners, including child welfare agencies, Medicaid agencies, courts, health care providers, schools, and community-based organizations, to take steps now to help people with opioid use disorder access MOUD without delay.
